Is long-term survival in Glioblastoma possible? Updated results of the EORTC/NCIC phase III randomized trial on radiotherapy (RT) and concomitant and adjuvant Temozolomide (TMZ) versus RT alone

被引：1
|
作者：
Mirimanoffr, R. [1 ]
Mason, W. [2 ]
Van den Bent, M. [3 ]
Kortmann, R. [4 ]
Taphoorn, M. [5 ]
Brandes, A. [6 ]
Villa, S. [7 ]
Cairncrosss, G. [8 ]
Gorlia, T. [9 ]
Stupp, R. [1 ]
机构：
[1] Univ Lausanne, Univ Hosp Ctr, Lausanne, Switzerland
[2] Princess Margaret Hosp, Toronto, ON, Canada
[3] Erasmus MC, Rotterdam, Netherlands
[4] Univ Tubingen Hosp, Tubingen, Germany
[5] Univ Med Ctr Utrecht, Utrecht, Netherlands
[6] Inst Oncol Veneto, Padua, Italy
[7] Inst Catala Oncol, Barcelona, Spain
[8] Univ Calgary, Calgary, AB, Canada
[9] European Org Res Treatment Canc, Brussels, Belgium
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group
    Stupp, R
    Mason, WP
    Van Den Bent, MJ
    Weller, M
    Fisher, B
    Taphoorn, M
    Brandes, AA
    Cairncross, G
    Lacombe, D
    Mirimanoff, RO
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 1S - 1S
  • [2] Radiotherapy (RT) and concomitant and adjuvant temozolomide (TMZ) versus radiotherapy alone for newly diagnosed glioblastoma (GBM): Overall results and recursive partitioning analysis (RPA) of a phase III randomized trial of the EORTC brain tumor and radiotherapy groups and the NCIC clinical trial group
    Mirimanoff, R
    Mason, W
    Kortmann, R
    Van den Bent, M
    Fisher, B
    Taphoorn, M
    Reni, M
    Curschmann, J
    Villa, S
    Cairncross, G
    Gorlia, T
    Stupp, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S162
  • [3] Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    Stupp, Roger
    Hegi, Monika E.
    Mason, Warren P.
    van den Bent, Martin J.
    Taphoorn, Martin J. B.
    Janzer, Robert C.
    Ludwin, Samuel K.
    Allgeier, Anouk
    Fisher, Barbara
    Belanger, Karl
    Hau, Peter
    Brandes, Alba A.
    Gijtenbeek, Johanna
    Marosi, Christine
    Vecht, Charles J.
    Mokhtari, Karima
    Wesseling, Pieter
    Villa, Salvador
    Eisenhauer, Elizabeth
    Gorlia, Thierry
    Weller, Michael
    Lacombe, Denis
    Cairncross, J. Gregory
    Mirimanoff, Rene-Olivier
    [J]. LANCET ONCOLOGY, 2009, 10 (05): : 459 - 466
  • [4] Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study
    Athanassiou, H
    Synodinou, M
    Maragoudakis, E
    Paraskevaidis, M
    Verigos, C
    Misailidou, D
    Antonadou, D
    Sarris, G
    Beroukas, K
    Karageorgis, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S162 - S163
  • [5] RADIOTHERAPY (RT) WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) IN GLIOBLASTOMA MULTIFORME (GBM) - LONG TERM RESULTS FROM A SINGLE UNITED KINGDOM CENTRE
    Haylock, B.
    Husband, D.
    Shenoy, A.
    Wong, H.
    Brodbelt, A.
    Walker, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S34 - S35
  • [6] Is long-term survival after glioblastoma multiforme treated by concurrent Temozolomide (TMZ) and radiotherapy possible?
    Micke, O.
    Schaefer, U.
    Schueller, P.
    Willich, N.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 : 142 - 142
  • [7] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Omuro, Antonio Marcilio Padula
    Beal, Kathryn
    McNeill, Katharine Anne
    Thomas, Alissa A.
    Lin, Xuling
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Yamada, Yoshiya
    Gorman, Greg
    Lamson, Michael
    Bavisotto, Linda M.
    Karmali, Rashida A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
    Thomas, Alissa A.
    Beal, Kathryn
    McNeill, Katharine Anne
    Kaley, Thomas Joseph
    DeAngelis, Lisa Marie
    Mellinghoff, Ingo K.
    Diamond, Eli L.
    Chan, Timothy An-thy
    Young, Robert J.
    Perez, Julio Arevalo
    Yamada, Yoshiya
    Anderson, Barry Douglas
    Lamson, Michael
    Burch, Brandon
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Commentary on Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5-Year Analysis of the EORTC-NCIC Trial (Lancet Oncol. 2009;10:459-466)
    Linz, Ute
    [J]. CANCER, 2010, 116 (08) : 1844 - 1846
  • [10] Trotabresib (CC-90010) combined with concomitant temozolomide (TMZ) plus radiotherapy (RT) and adjuvant TMZ in patients (pts) with newly diagnosed primary glioblastoma (ndGBM): Updated results from a phase Ib/II study
    Vieito Villar, M.
    Sepulveda Sanchez, J. M.
    Moreno Garcia, V.
    Lombardi, G.
    Stradella, A.
    Dahlrot, R. H.
    Haslund, C. A.
    Geurts, M.
    Pineda, E.
    Brandal, P.
    De Vos, F. Y. F. L.
    Vaz Salgado, M. A.
    Martinez Garcia, M.
    Macchini, M.
    Amoroso, B.
    Sanchez, T.
    Hanna, B.
    Li, X.
    Nikolova, Z.
    Simonelli, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S392 - S392
12345